Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-12-02-2003
Volume27
Issue 12

Sixth Annual International Employment Survey: Staying the Course

Author(s):

Maribel Rios

Despite continued industry-wide layoffs in manufacturing jobs during the past year, the pharmaceutical industry workforce continues a slow and steady pace.

External Link - article-78152.pdf

Articles in this issue
December 2003
All Signs Indicate a Strong 2004 for Contract Services
Behavior of Uptake of Moisture by Drugs and Excipients
A State of Revision: USP's Guideline for the Submission of Requests for Revision
Targeted Cationic Liposomes, Technologies, and Developments
Sixth Annual International Employment Survey: Staying the Course
Drug Pricing Concerns Shape Policy Decisions in 2003
In the Spotlight--January 2004
December 2003

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content
Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com
April 25th 2025

CN Bio Forms Strategic Partnership with Pharmaron to Develop OOC Technologies

Feliza Mirasol
Under the partnership, Pharmaron will validate and promote the application of CN Bio’s PhysioMimix technology and will integrate OOC technologies into its R&D platform.
Drug Solutions Podcast: Examining the State of Biopharma Investment
June 6th 2023

Drug Solutions Podcast: Examining the State of Biopharma Investment

Grant Playter
In this episode, Siegfried Schmitt, vice president, Technical at Parexel, discusses the state of biopharma investment in 2023.
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
March 25th 2025

AstraZeneca and Alteogen Sign License Agreement for Developing Subcutaneous Formulations of Oncology Assets

Feliza Mirasol
Under the agreement, AstraZeneca will use Alteogen’s proprietary hyaluronidase platform technology to develop and commercialize subcutaneous formulations of multiple oncology assets in its portfolio.
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
March 24th 2025

Latigo Biotherapeutics Raises $150 Million to Advance Non-Opioid Pain Therapeutics

Feliza Mirasol
With financing led by Blue Owl Capital, Latigo will use the funds to further develop non-opioid pain treatments as well as develop other candidates in its pipeline.
Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com
March 18th 2025

Shilpa Biologicals and mAbTree Biologics to Collaborate on Novel Immuno-Oncology Asset

Feliza Mirasol
The partnership aims to develop and commercialize a novel checkpoint inhibitor for immuno-oncology applications.
Young female tech or scientist performs protein assay | Image Credit: © tilialucida - stock.adobe.com
February 13th 2025

Leaving STEM Skills on the Table

Susan Haigney
Investing in STEM programs for girls in an education setting and then supporting women as they excel in their professional careers is key to ensuring that vital highly skilled personnel are not left behind.